News Releases Year: - Any -2021202020192018201720162015201420132012 Items per page 102550 08/26/20 Summary ToggleClearside Biomedical Expands Patent Portfolio in the U.S. and Europe PDF Version 08/10/20 Summary ToggleClearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update PDF Version 08/10/20 Summary ToggleClearside Biomedical Announces U.S. FDA Acceptance of Investigational New Drug Application for CLS-AX (axitinib injectable suspension) Administered in Suprachoroidal Space PDF Version 08/04/20 Summary ToggleClearside Biomedical to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference PDF Version 07/30/20 Summary ToggleClearside Biomedical to Report Second Quarter 2020 Financial Results and Provide Corporate Update on Monday, August 10, 2020 PDF Version 07/27/20 Summary ToggleClearside Biomedical Announces Multiple Presentations at the ASRS 2020 Virtual Annual Meeting PDF Version 06/17/20 Summary ToggleClearside Biomedical Announces Numerous Presentations at the ARVO 2020 Meeting PDF Version 05/08/20 Summary ToggleClearside Biomedical Announces First Quarter 2020 Financial Results PDF Version 04/28/20 Summary ToggleClearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch Health PDF Version 04/22/20 Summary ToggleClearside Biomedical Appoints Nancy J. Hutson, Ph.D. to its Board of Directors PDF Version Pagination First page First Previous page Page 1 Current page 2 Page 3 Page 4 Next page Last page Last
